Clinical trial
Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients
NCT00259025 · Aalborg University Hospital, Other · Completed
Key facts
| NCT number | NCT00259025 |
|---|---|
| Title | Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients |
| Official title | The Effect of Intravenous n-3 Polyunsaturated Fatty Acids on Risk Markers for Sudden Cardiac Death in Hemodialysis Patients |
| Lead sponsor | Aalborg University Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Renal Failure, Chronic |
| Intervention type | Drug |
| Interventions | lipid emulsion with a high content of n-3 fatty acids |
| Enrollment | 60 |
| Start date | Sep 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Nov 29, 2005 |
| Last update posted | Aug 11, 2008 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: